GE MEDICAL SYSTEMS

MedGenome appoints Dr Felix Olale as President and CEO, and Jennifer Rose as EVP and CCO to lead US operations, aiming to expand in North America through multiomics solutions for disease mechanisms, biomarkers, and personalized medicine.

Doug Meijer's prostate cancer treatment with theranostics in Germany led to full recovery, highlighting the potential of personalized cancer treatment. Experts predict theranostics will grow rapidly, but face competition in cancer care. Clinicians emphasize collaboration and open dialogue to maximize its benefits.

Medtronic settled a lawsuit over pulse oximeters' accuracy for darker skin, agreeing to provide labels and brochures to California hospitals. The FDA has delayed guidance on pulse oximeter accuracy since 2021, now prioritizing it for fiscal year 2025.

The study involved ethical approval, leukapheresis for NK cell production, and adherence to GMP regulations. NK cells were manufactured using CliniMACS Prodigy, with quality control including sterility testing, cell count, and viability analysis. Cell lines and primary NK cells were isolated and cultured for cytotoxicity and degranulation assays.

The global Head and Neck Cancer Diagnostics market is expected to grow from $6.8B in 2023 to $15.2B by 2030, driven by advancements in liquid biopsy, NGS, AI, and molecular testing. Rising cancer incidence, personalized medicine, and healthcare policies are key factors. The report offers detailed market analysis, competitive insights, and future trends.

Michelle Tarver, new FDA medical device center leader, faces challenges with AI, racial bias, recall process, and former leader's conflicts. Patient advocates seek stronger standards and transparent recalls; medtech companies aim to maintain U.S. as top market. Tarver's priorities include modern workforce, agility, and health equity. User fee discussions and device safety are also key areas of focus.

Michelle Tarver, new FDA medical device center director, faces challenges with AI, racial bias in devices, recall process, and former leader's conflicts. Patient advocates seek stronger standards and transparent recalls, while medtech companies hope for continued U.S. market leadership.

The article discusses the importance of enabling JavaScript for optimal app performance.

Oracle introduced an AI-driven EHR system at the Oracle Health Summit, aiming to enhance clinician efficiency and patient care through automation, insights, and streamlined workflows. The system includes Oracle Health Clinical AI Agent and Data Intelligence tools for personalized care plans and reduced treatment trial-and-error, with an early adopter program starting in 2025.

Retrospective study on TAO patients using ^99mTc-DTPA SPECT/CT, with 115 patients from Institution 1 and 58 from Institution 2. Data collected include patient characteristics, treatment, and follow-up. Hyperthyroidism and TAO treated with anti-thyroid drugs and glucocorticoids. SPECT/CT imaging and preprocessing detailed, with image quantization and feature extraction. Radiomics model established using mRMR and LASSO algorithms. Clinical and combined models evaluated for TAO activity assessment.